Clinical and mutational spectrum of Colombian patients with Pelizaeus Merzbacher Disease
Abstract
Pelizaeus Merzbacher Disease (PMD) is an X-linked developmental defect of myelination that causes a childhood chronic spastic encephalopathy. Its genetic aetiology can be either a duplication (or other gene dosage alterations) or a punctual mutation at the PLP1 locus. Clinically, it presents with developmental delay, nistagmus and spasticity, supported by neuroimaging in which the defect of myelination is evident. We present a series of 7 Colombian patients diagnosed with PMD, describing their genotypic and phenotypic characteristics and heterogeneity. We found PLP1 mutations in 71,5% of patients taken to molecular diagnosis and PLP1 duplications in the other 28,5%. We suggest that for Colombian population it might be better to start the confirmatory algorithm with full sequencing of the affected gene.Authors
Downloads
Keywords
- Pelizaeus Merzbacher disease
- child development
- developmental disorders
- myelin sheath
- Myelin proteolipidic protein
- PLP1
References
Pelizaeus F. U¨ber eine eigentu¨mliche Form spastischer La¨hmung mit cerebral Erscheinungen auf heredita¨rer Grund- lage. Arch Psychiatr Nervenkr. 1885; 16: 698 - 710.
Merzbacher L. Eine eigenartige familia¨re-heredita¨re Erkrankungsform (Aplasia axialis extracorticalis congenita). Z Ges Neurol Psychiatr. 1910; 3: 1-138.
Gencic S, Abuelo D, Ambler M, Hudson LD. Pelizaeus - Merzbacher Disease: An X - linked Neurologic Disorder of Myelin Metabolism with a Novel Mutation in the Gene Encoding Proteolipid Protein. Am J Hum Genet. 1989; 45: 435-42.
Genetics Home Reference. Gene PLP1. Fecha de Consulta: Agosto 01 de 2015. NIH: USA. 2008. Disponible en: http://ghr.nlm.nih.gov/gene/PLP1.
Hofman-Zacharska D, Mierzewska H, Szczepanik E, Poznanski J, Mazurczak T, Jakubiuk-Tomaszuk A, et al. The espectrum of PLP1 gene mutations in patients with classical form of the Pelizaeus Merzbacher disease. Developmental Period Medicine. 2013; XVII(4): 293-300.
Hobson GM, Garbern JY. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders. Semin Neurol. 2012; 32(1): 62-7.
Lee E, Yum M, Choi H, Yoo H, You SJ, Lee EH, et al. Magnetic resonance imaging and spectroscopic analysis in 5 cases of Pelizaeus-Merzbacher disease: metabolic abnormalities as diagnostic tools. Korean J Pediatr. 2012; 55(10): 397-402.
Inoue K. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Neurogenetics. 2005; 6: 1-16.
Garbern JY. Pelizaeus Merzbacher Disease. The portal for rare diseases and orphan drugs 2011; http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=702.
Hoffman-Zacharska D, Mierzewska H, Szczepanik E, Poznanski J, Mazurczak T, Jakubiuk-Tomaszuk A, et al. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease. Med Wieku Rozwoj. 2013; 17(4): 293-300.
Uniprot. UniProtKB - P60201 (MYPR_HUMAN). PLP1. Fecha de Consulta: Agosto 03 de 2015. Disponible en: http://www.uniprot.org/uniprot/P60201..
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use
